{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:09:23Z","timestamp":1792015763090,"version":"4.4.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Enteropathy-associated T-cell lymphoma (EATL) is a rare and highly aggressive subtype of non-Hodgkin lymphoma (NHL) that is strongly associated with celiac disease. It frequently manifests with severe complications, including intestinal obstruction or perforation, which underscores its adverse prognosis. Due to its rarity, the pathogenesis of EATL remains unclear, and standardized treatment protocols are lacking, necessitating further research to optimize management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>We present the case of a 69-year-old woman whose initial manifestation was gastroduodenal perforation and acute peritonitis. Two months later, she was readmitted due to a small intestinal perforation, requiring emergency partial small-bowel resection with side-to-side jejunojejunostomy. Postoperative histopathological examination confirmed the diagnosis of EATL. Furthermore, diagnostic work-up during her hospitalization revealed secondary bone involvement, a rare finding in this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case illustrates that EATL can manifest as life-threatening gastrointestinal perforation, which often necessitates urgent surgical intervention. It underscores the diagnostic challenge posed by this malignancy, especially when presenting atypically with rare extranodal involvement such as bone metastasis. A high index of suspicion, repeated biopsies, and early multidisciplinary collaboration are crucial for timely diagnosis and management of this aggressive lymphoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1748641","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:31:55Z","timestamp":1774416715000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: A case of jejunal T-cell non-Hodgkin lymphoma with secondary bone involvement presenting as gastrointestinal perforation"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuru","family":"Gao","sequence":"first","affiliation":[{"name":"Intensive Care Unit, Binzhou Medical University Hospital","place":["Shandong, Binzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Binzhou Medical University Hospital","place":["Shandong, Binzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hematology, Binzhou Medical University Hospital","place":["Binzhou, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lu","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Binzhou Medical University Hospital","place":["Shandong, Binzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Binzhou Medical University Hospital","place":["Shandong, Binzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Han","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Binzhou Medical University Hospital","place":["Shandong, Binzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.17219\/acem\/94068","article-title":"Gastrointestinal non-Hodgkin lymphomas","volume":"28","author":"Olszewska-Szopa","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"564875","DOI":"10.3389\/fmed.2020.564875","article-title":"Refractory celiac disease type II: A case report and literature review","volume":"7","author":"Chibbar","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ajh.25674","article-title":"Incidence and outcomes of rare T cell lymphomas from the T cell project: Hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas","volume":"95","author":"Foss","year":"2020","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra2304821","article-title":"Acute abdomen in the modern era","volume":"391","author":"Selwyn O Rogers","year":"2024","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3238\/arztebl.m2025.0019","article-title":"The acute abdomen: structured diagnosis and treatment","volume":"122","author":"B\u00f6rner","year":"2025","journal-title":"Dtsch Arztebl Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/annonc\/mdt188","article-title":"Bowel perforation in intestinal lymphoma: incidence and clinical features","volume":"24","author":"Vaidya","year":"2013","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.6004\/jnccn.2022.0015","article-title":"T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Horwitz","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pathol.2019.10.001","article-title":"T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update","volume":"52","author":"van Vliet","year":"2020","journal-title":"Pathology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood.2023021786","article-title":"A practical approach to the modern diagnosis and classification of T-and NK-cell lymphomas","volume":"144","author":"de Leval","year":"2024","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1182\/blood.2023021788","article-title":"Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL, MEITL, SPTCL, and HSTCL)","volume":"144","author":"Marchi","year":"2024","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.3390\/cancers13225774","article-title":"Primary gastrointestinal T-cell lymphoma and indolent lymphoproliferative disorders: practical diagnostic and treatment approaches","volume":"13","author":"Nishimura","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref13","first-page":"77","article-title":"Enteropathy-associated T-cell lymphoma (EATL) with intracranial metastasis: a rare and dismal condition","volume":"83","author":"Chuah","year":"2020","journal-title":"Acta Gastroenterol Belg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/diagnostics13162629","article-title":"Update on the pathogenesis of enteropathy-associated T-cell lymphoma","volume":"13","author":"Abdullah","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/diagnostics15121511","article-title":"Diagnostic challenges in enteropathies: a histopathological review","volume":"15","author":"Enache","year":"2025","journal-title":"Diagnostics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1241","DOI":"10.1136\/rmdopen-2020-001241","article-title":"Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002\u20132017","volume":"6","author":"Singh","year":"2020","journal-title":"RMD Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/annrheumdis-2014-205847","article-title":"Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme","volume":"75","author":"Curtis","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s11899-021-00634-4","article-title":"Enteropathy-associated T cell lymphoma","volume":"16","author":"Al Somali","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1053\/j.gastro.2023.06.003","article-title":"Incidence and survival in patients with enteropathy-associated T-cell lymphoma: Nationwide registry studies from England and Denmark","volume":"165","author":"West","year":"2023","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.14309\/ajg.0000000000002666","article-title":"The rising incidence and poor outcomes of enteropathy-associated T-cell lymphoma","volume":"119","author":"Hujoel","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1016\/S2352-3026(24)00171-6","article-title":"Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 study","volume":"11","author":"Herrera","year":"2024","journal-title":"Lancet Haematol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1748641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:32:05Z","timestamp":1774416725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1748641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1748641"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1748641","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"article-number":"1748641"}}